Skip to main content

LMR Partners LLP

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1578621 LONDON, X0

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$230,100
-$109,200 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 168 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Derivatives in FULC

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
0
PutValue
$150,297
PutShares
42,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LMR Partners LLP holds $223,407,665 across 59 Biotechnology names. FULC ranks #41 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $230,100 30,000
2025-12-31 $339,300 30,000
2025-09-30 $276,000 30,000
2025-06-30 $344,000 50,000
2024-12-31 $528,750 112,500
2024-09-30 $150,297 42,100
2024-03-31 $165,568 17,539
2021-09-30 $846,300 30,000